Geron (GERN) Reports Partical FDA Clinical Hold on Imetelstat in Myelofibrosis IST
Tweet Send to a Friend
Geron Corporation (Nasdaq: GERN) announced that patients currently enrolled in the investigator-sponsored clinical trial of imetelstat in myelofibrosis (Myelofibrosis IST) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE